Prof. Dr. Nikolaus Marx on behalf of the EMPEROR Trial Committees
t
Germany
Vortrag
Impact of Empagliflozin on Insulin Use in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF) and Type 2 Diabetes (T2DM): Sub-Analysis from EMPEROR-Preserved Trial
Speaker
